Weight-loss solutions designed to transform and sustain
Longevity medications designed to extend and enhance
We offer personalized GLP-1 prescriptions, including our game-changing Semaglutide Lozenges—a powerful, needle-free alternative to injections. Designed for ease and convenience, these lozenges may be prescribed as part of a personalized weight management plan. No needles, no hassle—just another science-backed tool to bring you exciting results.






Wegovy® is now available as a once-daily pill, offering a needle-free option for people who prefer oral medication. Like the Wegovy® pen, the pill contains semaglutide and is FDA-approved for chronic weight management.
This new delivery method gives patients more flexibility in how they take Wegovy®, while still receiving provider-guided care through Shed.

*In clinical trials of Wegovy® (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise. This compares to approximately 2–3% weight loss with diet and exercise alone.















Compounded medications are prepared by licensed pharmacies to meet the specific needs of individual patients. These medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. However, they are made in accordance with strict regulatory guidelines. Prescription is only available after consultation with a licensed provider to determine if treatment is appropriate. If your clinician determines that a compounded medication is clinically appropriate for you, please be aware that it is not an FDA-approved product.
Ozempic®, Wegovy®, and Rybelsus® are the only FDA-approved products containing semaglutide produced by Novo Nordisk, Inc., while Zepbound® and Mounjaro® are the only FDA-approved products containing tirzepatide produced by Lilly USA LLC.




We offer personalized GLP-1 prescriptions, including our game-changing Semaglutide Lozenges—a powerful, needle-free alternative to injections. Designed for ease and convenience, these lozenges may be prescribed as part of a personalized weight management plan. No needles, no hassle—just another science-backed tool to bring you exciting results.




We offer personalized GLP-1 prescriptions, including our game-changing Semaglutide Lozenges—a powerful, needle-free alternative to injections. Designed for ease and convenience, these lozenges may be prescribed as part of a personalized weight management plan. No needles, no hassle—just another science-backed tool to bring you exciting results.







Doctor of Medicine (MD),
Internal Medicine Physician
While GLP-1 microdosing is ideal for maintenance, longevity, and overall wellness support, those with a significant weight-loss goal may be better suited for a standard GLP-1 dose.

Compounded medications are prepared by licensed pharmacies to meet the specific needs of individual patients. These medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. However, they are made in accordance with strict regulatory guidelines. Prescription is only available after consultation with a licensed provider to determine if treatment is appropriate. If your clinician determines that a compounded medication is clinically appropriate for you, please be aware that it is not an FDA-approved product.
Ozempic®, Wegovy®, and Rybelsus® are the only FDA-approved products containing semaglutide produced by Novo Nordisk, Inc., while Zepbound® and Mounjaro® are the only FDA-approved products containing tirzepatide produced by Lilly USA LLC.
Weight-loss solutions designed to transform and sustain
Longevity medications designed to extend and enhance